Sleep Disorders Drug Development Pipeline Review, 2017
This report provides an overview of the pipeline landscape for sleep disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Restless Legs Syndrome, Nocturia and Insomnia, and features dormant and discontinued projects.
Restless Legs Syndrome is a neurologic disorder with a core feature of a distressing, irresistible need or urge to move the legs. Risk factors for RLS include low iron levels, kidney failure, Parkinson's disease, diabetes mellitus, rheumatoid arthritis, and pregnancy.
Nocturia, or nocturnal polyuria, describes the excessive urination during night time. Nocturia becomes more common with age and may be symptomatic of the use of diuretic substances, prescription drugs, edema from heart failure, insomnia, pain and prostate or bladder disorders.
Finally, insomnia is a sleep disorder that is characterized by difficulty in falling or staying asleep. Symptoms include difficulty falling asleep at night, waking up during the night, irritability, depression and anxiety.
The size of these pipelines ranges from eight products in restless legs syndrome and nocturia to 31 in insomnia. Across all three of these indications there is a diverse range of molecular targets due to the different pathologies of the indications. The most common targets for restless legs syndrome, nocturia and insomnia therapeutics are D2 dopamine receptor, vasopressin V2 receptor and orexin receptor, respectively.
- Which companies are the most active within the pipeline for sleep disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of sleep disorders?
To Get Sample Copy of Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=41647
Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
To view a detailed description and Table of Contents please visit: https://www.reportsworldwide.com/report/sleep-disorders-drug-development-pipeline-review-2017
ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.
Senior Vice President
101, Arch Street
Phone +1 (617) 398-1947
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sleep Disorders Drug Development Pipeline Review, 2017 here
News-ID: 784088 • Views: 216
More Releases from ReportsWorldwide
World Deep Brain Stimulation Market Top Segments, Key Players Revenue, Growth Ra …
The World Deep Brain Stimulation Market is estimated to represent a global market of USD 751.8 million by 2017 with growth rate of 18.2%. Deep brain stimulation (DBS) procedure is primarily used for the treatment of neuropsychiatric disorders such as mood disorder, dementia, anxiety and others. The procedure involve the use of neurotransmitter (brain pacemaker) that enables to transmit electric impulses to the specific target of brain cells. Increasing incidence
New report explores the Gene Editing Market : Ushering The Next Breakthrough in …
Boston, MA ReportsWorldwide has announced the addition of a new report title Gene Editing The Next Breakthrough in Regenerative Medicine to its growing collection of premium market research reports. Genome editing is a type of genetic engineering in which DNA is replaced, inserted or deleted in a living organism's ggenome using engineered molecular scissors. Believed to be one of the great biotechnology breakthroughs, gene editing is a powerful tool in pharmaceutical research that
Global In-Building Wireless BTSController-based Small Cells Market Analysis and …
Boston, MA ReportsWorldwide has announced the addition of a new report title Global In-Building Wireless BTSController-based Small Cells Market Analysis and Forecast, 2017-2021 to its growing collection of premium market research reports. This report covers the leading in-building wireless enterprise BTS/controller-based small cells network equipment manufacturers: • CommScope/Airvana • Comba Telecom • Ericsson • Huawei Technologies • Nokia • SpiderCloud • ZTE Corporation This report covers the global market share for 2016 shipments as well as a forecast for 2017-2021. To view a detailed description and Table of
UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply …
Boston, MA ReportsWorldwide has announced the addition of a new report title UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply Chain in India – 2017 to its growing collection of premium market research reports. UDAY scheme was touted as the next paladin to bail out the struggling Discoms, in order to turn them green in a time horizon of 3-4 years from 2015/16. Though was optional for the
More Releases for Sleep
The U.S. Sleep Market
Bharat Book Bureau Provides the Trending Market Research Report on “The U.S. Sleep Market” under "Life Sciences" category. The report provides information on industry overview, market size, latest developments, industry trends, Key players, global presence, and their future prospects. Of a total population of 325 million Americans, 58% are estimated to experience insomnia symptoms or sleep disorders. Companies across America are trying to sell us a perfect night’s sleep with medications,
Sleep Aids Market 2016: Insomnia, Sleep Apnea, Narcolepsy
Sleeps aids are drugs and medical devices that treats sleep disorder or insomnia. Sleep disorder or insomnia is generally caused due to change in sleeping pattern, substance misuse and work issues. Most recent development in Sleep aids involves the use of specialty mattresses, high-tech pillows, drugs and at-home tests. The concept of sleep aids have outpaced the traditional methods as they are effective in reducing the time taken to fall
Slick Sleep supplies complete range of organic sleep products for better sleep a …
United States 04-03-2016. Slick Sleep is the leading supplier of organic sleep products ideal to give you better sleep at night. There is wide variety of sleep products in the market to choose from and all are pertinent to meet your variant specifications. Everyone may experience different type of sleep issues and to deal with them you need the right medicine or precaution. The most common reason of improper sleep
“Sleep Awareness Week” - Sleep Apnea In Children Can Be Cured!
National Sleep Awareness Week March 6-13, 2016 San Diego, CA - TMJ & Sleep Therapy Centre joins National Sleep Foundation in their focus to bring the importance of sleep awareness and education to the American public. NIH (National Institutes for Health) has identified that sleep related breathing problems such as obstructive sleep apnea and snoring affect 50 to 70 million Americans. Obstructive sleep apnea has no age boundaries; it affects both
Sleep & Wellness 2014 conference announced
The American Sleep & Breathing Academy (ASBA) has announced “Sleep & Wellness 2014: A Conference for Professionals.” The conference will be held in Scottsdale, Arizona, on May 1-3, 2014. With its multidisciplinary approach to sleep medicine education, this conference will be the first of its kind. The event will be geared toward physicians, dentists, physician’s assistants, nurse practitioners, respiratory therapists and sleep technicians. Continuing Medical and Dental Education will be
Sleep & Wellness 2014 Conference announced
The American Sleep & Breathing Academy (ASBA) has announced “Sleep & Wellness 2014: A Conference for Professionals.” The conference will be held in Scottsdale, Arizona, on May 1-3, 2014. With its multidisciplinary approach to sleep medicine education, this conference will be the first of its kind. The event will be geared toward physicians, dentists, physician’s assistants, nurse practitioners, respiratory therapists and sleep technicians and technologists. Continuing Medical and Dental Education